Barbara Kee - Publications

Affiliations: 
Immunology University of Chicago, Chicago, IL 

63 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Parriott G, Hegermiller E, Morman RE, Frank C, Saygin C, Stock W, Bartom ET, Kee BL. Loss of thymocyte competition underlies the tumor suppressive functions of the E2a transcription factor in T-ALL. Leukemia. PMID 38155245 DOI: 10.1038/s41375-023-02123-4  0.318
2023 Parriott G, Hegermiller E, Morman RE, Frank C, Saygin C, Stock W, Bartom ET, Kee BL. Loss of thymocyte competition underlies the tumor suppressive functions of the E2a transcription factor in T lymphocyte acute lymphoblastic leukemia. Biorxiv : the Preprint Server For Biology. PMID 37163059 DOI: 10.1101/2023.04.23.537993  0.328
2022 Morgan RC, Kee BL. Genomic and Transcriptional Mechanisms Governing Innate-like T Lymphocyte Development. Journal of Immunology (Baltimore, Md. : 1950). 209: 208-216. PMID 35821098 DOI: 10.4049/jimmunol.2200141  0.34
2022 Parriott G, Kee BL. E Protein Transcription Factors as Suppressors of T Lymphocyte Acute Lymphoblastic Leukemia. Frontiers in Immunology. 13: 885144. PMID 35514954 DOI: 10.3389/fimmu.2022.885144  0.301
2021 Li ZY, Morman RE, Hegermiller E, Sun M, Bartom ET, Maienschein-Cline M, Sigvardsson M, Kee BL. The transcriptional repressor ID2 supports natural killer cell maturation by controlling TCF1 amplitude. The Journal of Experimental Medicine. 218. PMID 33857289 DOI: 10.1084/jem.20202032  0.334
2020 Gioulbasani M, Galaras A, Grammenoudi S, Moulos P, Dent AL, Sigvardsson M, Hatzis P, Kee BL, Verykokakis M. The transcription factor BCL-6 controls early development of innate-like T cells. Nature Immunology. PMID 32719520 DOI: 10.1038/S41590-020-0737-Y  0.38
2020 Kee BL, Morman RE, Sun M. Transcriptional regulation of natural killer cell development and maturation. Advances in Immunology. 146: 1-28. PMID 32327150 DOI: 10.1016/Bs.Ai.2020.01.001  0.408
2020 Jacobsen JA, Bartom ET, Sigvardsson M, Kee BL. Ezh2 Represses Transcription of Innate Lymphoid Genes in B Lymphocyte Progenitors and Maintains the B-2 Cell Fate. Journal of Immunology (Baltimore, Md. : 1950). 204: 1760-1769. PMID 32094206 DOI: 10.4049/jimmunol.1901188  0.502
2019 Pham D, Moseley CE, Gao M, Savic D, Winstead CJ, Sun M, Kee BL, Myers RM, Weaver CT, Hatton RD. Batf Pioneers the Reorganization of Chromatin in Developing Effector T Cells via Ets1-Dependent Recruitment of Ctcf. Cell Reports. 29: 1203-1220.e7. PMID 31665634 DOI: 10.1016/J.Celrep.2019.09.064  0.339
2019 Durai V, Bagadia P, Granja JM, Satpathy AT, Kulkarni DH, Davidson JT, Wu R, Patel SJ, Iwata A, Liu TT, Huang X, Briseño CG, Grajales-Reyes GE, Wöhner M, Tagoh H, ... Kee BL, et al. Cryptic activation of an Irf8 enhancer governs cDC1 fate specification. Nature Immunology. PMID 31406378 DOI: 10.1038/S41590-019-0450-X  0.329
2019 de Pooter RF, Dias S, Chowdhury M, Bartom ET, Okoreeh MK, Sigvardsson M, Kee BL. Cutting Edge: Lymphomyeloid-Primed Progenitor Cell Fates Are Controlled by the Transcription Factor Tal1. Journal of Immunology (Baltimore, Md. : 1950). PMID 30962294 DOI: 10.4049/jimmunol.1801220  0.353
2018 Zook EC, Li ZY, Xu Y, de Pooter RF, Verykokakis M, Beaulieu A, Lasorella A, Maienschein-Cline M, Sun JC, Sigvardsson M, Kee BL. Transcription factor ID2 prevents E proteins from enforcing a naïve T lymphocyte gene program during NK cell development. Science Immunology. 3. PMID 29703840 DOI: 10.1126/Sciimmunol.Aao2139  0.397
2018 Verykokakis M, Kee BL. Transcriptional and epigenetic regulation of innate-like T lymphocyte development. Current Opinion in Immunology. 51: 39-45. PMID 29452898 DOI: 10.1016/j.coi.2018.01.006  0.346
2017 Jacobsen JA, Woodard J, Mandal M, Clark MR, Bartom ET, Sigvardsson M, Kee BL. EZH2 Regulates the Developmental Timing of Effectors of the Pre-Antigen Receptor Checkpoints. Journal of Immunology (Baltimore, Md. : 1950). PMID 28490575 DOI: 10.4049/jimmunol.1700319  0.384
2017 Verykokakis M, Kee BL. Applying the TOR(C)QUE in iNKT cells: A new twist in an old tale. European Journal of Immunology. 47: 454-457. PMID 28295259 DOI: 10.1002/eji.201746921  0.373
2017 Gabrielli S, Sun M, Bell A, Zook EC, de Pooter RF, Zamai L, Kee BL. Murine thymic NK cells are distinct from ILC1s and have unique transcription factor requirements. European Journal of Immunology. PMID 28276053 DOI: 10.1002/Eji.201646871  0.339
2016 Zook EC, Kee BL. Development of innate lymphoid cells. Nature Immunology. 17: 775-82. PMID 27328007 DOI: 10.1038/ni.3481  0.334
2016 Zook EC, Ramirez K, Guo X, van der Voort G, Sigvardsson M, Svensson EC, Fu YX, Kee BL. The ETS1 transcription factor is required for the development and cytokine-induced expansion of ILC2. The Journal of Experimental Medicine. PMID 27069114 DOI: 10.1084/Jem.20150851  0.306
2015 Xu Y, Evaristo C, Alegre ML, Gurbuxani S, Kee BL. Analysis of GzmbCre as a Model System for Gene Deletion in the Natural Killer Cell Lineage. Plos One. 10: e0125211. PMID 25923440 DOI: 10.1371/Journal.Pone.0125211  0.364
2015 Carr T, Krishnamoorthy V, Yu S, Xue HH, Kee BL, Verykokakis M. The transcription factor lymphoid enhancer factor 1 controls invariant natural killer T cell expansion and Th2-type effector differentiation. The Journal of Experimental Medicine. 212: 793-807. PMID 25897173 DOI: 10.1084/jem.20141849  0.381
2015 Xu W, Domingues RG, Fonseca-Pereira D, Ferreira M, Ribeiro H, Lopez-Lastra S, Motomura Y, Moreira-Santos L, Bihl F, Braud V, Kee B, Brady H, Coles MC, Vosshenrich C, Kubo M, et al. NFIL3 orchestrates the emergence of common helper innate lymphoid cell precursors. Cell Reports. 10: 2043-54. PMID 25801035 DOI: 10.1016/J.Celrep.2015.02.057  0.494
2015 Krishnamoorthy V, Carr T, de Pooter RF, Emanuelle AO, Akinola EO, Gounari F, Kee BL. Repression of Ccr9 transcription in mouse T lymphocyte progenitors by the Notch signaling pathway. Journal of Immunology (Baltimore, Md. : 1950). 194: 3191-200. PMID 25710912 DOI: 10.4049/jimmunol.1402443  0.364
2014 Verykokakis M, Zook EC, Kee BL. ID'ing innate and innate-like lymphoid cells. Immunological Reviews. 261: 177-97. PMID 25123285 DOI: 10.1111/imr.12203  0.374
2014 Kee BL. Sox4 B-lymphocyte progenitors. Blood. 123: 4009-10. PMID 24970928 DOI: 10.1182/blood-2014-05-574178  0.339
2013 Xu W, Carr T, Ramirez K, McGregor S, Sigvardsson M, Kee BL. E2A transcription factors limit expression of Gata3 to facilitate T lymphocyte lineage commitment. Blood. 121: 1534-42. PMID 23297135 DOI: 10.1182/blood-2012-08-449447  0.374
2012 Pereira de Sousa A, Berthault C, Granato A, Dias S, Ramond C, Kee BL, Cumano A, Vieira P. Inhibitors of DNA binding proteins restrict T cell potential by repressing Notch1 expression in Flt3-negative common lymphoid progenitors. Journal of Immunology (Baltimore, Md. : 1950). 189: 3822-30. PMID 22972921 DOI: 10.4049/jimmunol.1103723  0.422
2012 Ramirez K, Chandler KJ, Spaulding C, Zandi S, Sigvardsson M, Graves BJ, Kee BL. Gene deregulation and chronic activation in natural killer cells deficient in the transcription factor ETS1. Immunity. 36: 921-32. PMID 22608498 DOI: 10.1016/J.Immuni.2012.04.006  0.378
2011 Tran AH, Berger A, Wu GE, Kee BL, Paige CJ. Early B-cell factor regulates the expression of Hemokinin-1 in the olfactory epithelium and differentiating B lymphocytes. Journal of Neuroimmunology. 232: 41-50. PMID 20965576 DOI: 10.1016/J.Jneuroim.2010.09.027  0.653
2010 Gómez-del Arco P, Kashiwagi M, Jackson AF, Naito T, Zhang J, Liu F, Kee B, Vooijs M, Radtke F, Redondo JM, Georgopoulos K. Alternative promoter usage at the Notch1 locus supports ligand-independent signaling in T cell development and leukemogenesis. Immunity. 33: 685-98. PMID 21093322 DOI: 10.1016/J.Immuni.2010.11.008  0.43
2010 De Keersmaecker K, Real PJ, Gatta GD, Palomero T, Sulis ML, Tosello V, Van Vlierberghe P, Barnes K, Castillo M, Sole X, Hadler M, Lenz J, Aplan PD, Kelliher M, Kee BL, et al. The TLX1 oncogene drives aneuploidy in T cell transformation. Nature Medicine. 16: 1321-7. PMID 20972433 DOI: 10.1038/Nm.2246  0.354
2010 de Pooter RF, Kee BL. E proteins and the regulation of early lymphocyte development. Immunological Reviews. 238: 93-109. PMID 20969587 DOI: 10.1111/j.1600-065X.2010.00957.x  0.46
2010 Sousa Ad, Dias S, Kee B, Cumano A, Vieira P, Rodewald HR, Martins VC, Feyerabend TB, Schlenner SM, Bhandoola A, Bell JJ, Chi A, Zlotoff D, Takahama Y, Taniuchi I, et al. Early lymphocyte development (SY3-1) Chairpersons: Yousuke Takahama, Ana Cumano International Immunology. 22. DOI: 10.1093/Intimm/Dxq147  0.337
2009 Mandal M, Powers SE, Ochiai K, Georgopoulos K, Kee BL, Singh H, Clark MR. Ras orchestrates exit from the cell cycle and light-chain recombination during early B cell development. Nature Immunology. 10: 1110-7. PMID 19734904 DOI: 10.1038/Ni.1785  0.413
2009 Kee BL. E and ID proteins branch out. Nature Reviews. Immunology. 9: 175-84. PMID 19240756 DOI: 10.1038/nri2507  0.317
2009 Gatta GD, Palomero T, Sulis ML, Solé X, Lim WK, De Keersmaecker K, Luna PJR, Tosello V, Gounari F, Kee B, Lenz J, Kelliher M, Aplan PD, Meijerink JP, Califano A, et al. Oncogenic Transcriptional Programs Controlled by TLX1/HOX11 and TLX3/HOX11L2 in T-ALL. Blood. 114: 676-676. DOI: 10.1182/Blood.V114.22.676.676  0.403
2009 De Keersmaecker K, Luna PJR, Gatta GD, Palomero T, Castillo M, Sulis ML, Tosello V, Gounari F, Kee B, Lenz J, Kelliher M, Aplan PD, Cordon-Cardo C, Ferrando AA. The HOX11/TLX1 Transcription Factor Oncogene Induces Chromosomal Aneuploidy in T-ALL. Blood. 114: 142-142. DOI: 10.1182/Blood.V114.22.142.142  0.427
2008 Dias S, Xu W, McGregor S, Kee B. Transcriptional regulation of lymphocyte development. Current Opinion in Genetics & Development. 18: 441-8. PMID 18775782 DOI: 10.1016/J.Gde.2008.07.015  0.541
2008 Dias S, Månsson R, Gurbuxani S, Sigvardsson M, Kee BL. E2A proteins promote development of lymphoid-primed multipotent progenitors. Immunity. 29: 217-27. PMID 18674933 DOI: 10.1016/j.immuni.2008.05.015  0.404
2008 Boos MD, Ramirez K, Kee BL. Extrinsic and intrinsic regulation of early natural killer cell development. Immunologic Research. 40: 193-207. PMID 18266115 DOI: 10.1007/s12026-007-8006-9  0.334
2008 Bhalla S, Spaulding C, Brumbaugh RL, Zagort DE, Massari ME, Murre C, Kee BL. differential roles for the E2A activation domains in B lymphocytes and macrophages. Journal of Immunology (Baltimore, Md. : 1950). 180: 1694-703. PMID 18209066 DOI: 10.4049/Jimmunol.180.3.1694  0.571
2007 Spaulding C, Reschly EJ, Zagort DE, Yashiro-Ohtani Y, Beverly LJ, Capobianco A, Pear WS, Kee BL. Notch1 co-opts lymphoid enhancer factor 1 for survival of murine T-cell lymphomas. Blood. 110: 2650-8. PMID 17585052 DOI: 10.1182/Blood-2007-04-084202  0.354
2007 Nutt SL, Kee BL. The Transcriptional Regulation of B Cell Lineage Commitment Immunity. 26: 715-725. PMID 17582344 DOI: 10.1016/j.immuni.2007.05.010  0.525
2007 Boos MD, Yokota Y, Eberl G, Kee BL. Mature natural killer cell and lymphoid tissue-inducing cell development requires Id2-mediated suppression of E protein activity. The Journal of Experimental Medicine. 204: 1119-30. PMID 17452521 DOI: 10.1084/Jem.20061959  0.374
2007 Welner RS, Pelayo R, Garrett KP, Chen X, Perry SS, Sun XH, Kee BL, Kincade PW. Interferon-producing killer dendritic cells (IKDCs) arise via a unique differentiation pathway from primitive c-kitHiCD62L+ lymphoid progenitors. Blood. 109: 4825-931. PMID 17317852 DOI: 10.1182/Blood-2006-08-043810  0.417
2007 Xu W, Kee BL. Growth factor independent 1B (Gfi1b) is an E2A target gene that modulates Gata3 in T-cell lymphomas. Blood. 109: 4406-14. PMID 17272506 DOI: 10.1182/blood-2006-08-043331  0.399
2006 Kee BL. Helix-loop-helix proteins in lymphocyte lineage determination. Current Topics in Microbiology and Immunology. 290: 15-27. PMID 16480037 DOI: 10.1007/3-540-26363-2_2  0.382
2006 Reschly EJ, Spaulding C, Vilimas T, Graham WV, Brumbaugh RL, Aifantis I, Pear WS, Kee BL. Notch1 promotes survival of E2A-deficient T cell lymphomas through pre-T cell receptor-dependent and -independent mechanisms. Blood. 107: 4115-21. PMID 16449526 DOI: 10.1182/Blood-2005-09-3551  0.329
2006 Sulis ML, Palomero T, Real PJ, Barnes KC, Aplan P, Copeland N, Utpal D, Gounari F, Grosveld G, Kappes DJ, Kee B, Kelliher M, Lenz J, Richardson C, Ferrando A. Identification of Oncogenic Pathways of T-Acute Lymphoblastic Leukemia (T-ALL) through Gene Expression Profiling of Mouse Tumor Models. Blood. 108: 2234-2234. DOI: 10.1182/Blood.V108.11.2234.2234  0.373
2005 Friedrich ML, Wen BG, Bain G, Kee BL, Katayama C, Murre C, Hedrick SM, Walsh CM. DRAK2, a lymphoid-enriched DAP kinase, regulates the TCR activation threshold during thymocyte selection. International Immunology. 17: 1379-90. PMID 16172133 DOI: 10.1093/Intimm/Dxh315  0.525
2005 Osborne BA, Kee BL. Lymphoid development: it's not 'all Greek to us' any more. Nature Immunology. 6: 119-23. PMID 15662436 DOI: 10.1038/Ni0205-119  0.317
2004 Seet CS, Brumbaugh RL, Kee BL. Early B cell factor promotes B lymphopoiesis with reduced interleukin 7 responsiveness in the absence of E2A. The Journal of Experimental Medicine. 199: 1689-700. PMID 15210745 DOI: 10.1084/jem.20032202  0.52
2002 Kee BL, Bain G, Murre C. IL-7Ralpha and E47: independent pathways required for development of multipotent lymphoid progenitors. The Embo Journal. 21: 103-13. PMID 11782430 DOI: 10.1093/Emboj/21.1.103  0.57
2001 Kee BL, Murre C. Transcription factor regulation of B lineage commitment. Current Opinion in Immunology. 13: 180-5. PMID 11228411 DOI: 10.1016/S0952-7915(00)00202-8  0.69
2001 Kee BL, Rivera RR, Murre C. Id3 inhibits B lymphocyte progenitor growth and survival in response to TGF-beta. Nature Immunology. 2: 242-7. PMID 11224524 DOI: 10.1038/85303  0.522
2000 Kee BL, Quong MW, Murre C. E2A proteins: essential regulators at multiple stages of B-cell development Immunological Reviews. 175: 138-149. DOI: 10.1111/J.1600-065X.2000.Imr017514.X  0.698
1998 Kee BL, Murre C. Induction of early B cell factor (EBF) and multiple B lineage genes by the basic helix-loop-helix transcription factor E12. The Journal of Experimental Medicine. 188: 699-713. PMID 9705952 DOI: 10.1084/Jem.188.4.699  0.684
1997 Kee BL, Paige CJ. In vitro tracking of IL-7 responsiveness and gene expression during commitment of bipotent B-cell/macrophage progenitors. Current Biology : Cb. 6: 1159-69. PMID 8805368 DOI: 10.1016/S0960-9822(02)70683-0  0.692
1995 Kee BL, Paige CJ. Murine B cell development: commitment and progression from multipotential progenitors to mature B lymphocytes. International Review of Cytology. 157: 129-79. PMID 7706019 DOI: 10.1016/S0074-7696(08)62158-0  0.68
1995 Kee BL, Paige CJ. In-vitro models of B-lineage commitment. Seminars in Immunology. 7: 143-54. PMID 7579201 DOI: 10.1016/1044-5323(95)90042-X  0.677
1995 Marshall AJ, Kee BL, Paige CJ, Wu GE. Analysis of immunoglobulin gene rearrangement in fetal B-cell progenitors developing in vivo or in vitro. Annals of the New York Academy of Sciences. 764: 222-3. PMID 7486527 DOI: 10.1111/J.1749-6632.1995.Tb55830.X  0.664
1994 Cumano A, Kee BL, Ramsden DA, Marshall A, Paige CJ, Wu GE. Development of B lymphocytes from lymphoid committed and uncommitted progenitors. Immunological Reviews. 137: 5-33. PMID 8034337 DOI: 10.1111/J.1600-065X.1994.Tb00657.X  0.659
1994 Kee BL, Cumano A, Iscove NN, Paige CJ. Stromal cell independent growth of bipotent B cell--macrophage precursors from murine fetal liver. International Immunology. 6: 401-7. PMID 7514441 DOI: 10.1093/Intimm/6.3.401  0.641
1992 Kee BL, Paige CJ, Letarte M. Characterization of murine CD10, an endopeptidase expressed on bone marrow adherent cells. International Immunology. 4: 1041-7. PMID 1390435 DOI: 10.1093/Intimm/4.9.1041  0.519
Show low-probability matches.